ABVC BIOPHARMA, INC. Earnings Per Share Disclosure
14. LOSS PER SHARE
Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the year. Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the years ended December 31, 2024 and 2023.
| For the Year Ended | ||||||||
| December 31, 2024 |
December 31, 2023 |
|||||||
| Numerator: | ||||||||
| Net loss attributable to ABVC’s common stockholders | $ | (4,902,878 | ) | $ | (7,788,050 | ) | ||
| Denominator: | ||||||||
| Weighted-average shares outstanding – Basic & Diluted | 11,673,980 | 4,335,650 | ||||||
| Loss per share | ||||||||
| -Basic & Diluted | $ | (0.42 | ) | $ | (1.80 | ) | ||
Diluted loss per share takes into account the potential dilution that could occur if securities or other contracts to issue Common Stock were exercised and converted into Common Stock. Since the Company suffered net loss for both years, any diluted shares would have anti-diluted effect.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2024 | Apr 15, 2025 | Showing above |
| 2023 | Mar 13, 2024 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.